145 related articles for article (PubMed ID: 16950188)
1. Plasma myeloperoxidase levels in patients with chronic heart failure.
Tang WH; Brennan ML; Philip K; Tong W; Mann S; Van Lente F; Hazen SL
Am J Cardiol; 2006 Sep; 98(6):796-9. PubMed ID: 16950188
[TBL] [Abstract][Full Text] [Related]
2. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL
Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
[TBL] [Abstract][Full Text] [Related]
3. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
Ng LL; Pathik B; Loke IW; Squire IB; Davies JE
Am Heart J; 2006 Jul; 152(1):94-101. PubMed ID: 16824837
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
[TBL] [Abstract][Full Text] [Related]
6. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
7. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
8. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Fukunaga T; Soejima H; Irie A; Sugamura K; Oe Y; Tanaka T; Nagayoshi Y; Kaikita K; Sugiyama S; Yoshimura M; Nishimura Y; Ogawa H
Am J Cardiol; 2007 Aug; 100(3):483-8. PubMed ID: 17659933
[TBL] [Abstract][Full Text] [Related]
9. Urinary biopyrrins levels are elevated in relation to severity of heart failure.
Hokamaki J; Kawano H; Yoshimura M; Soejima H; Miyamoto S; Kajiwara I; Kojima S; Sakamoto T; Sugiyama S; Hirai N; Shimomura H; Nagayoshi Y; Tsujita K; Shioji I; Sasaki S; Ogawa H
J Am Coll Cardiol; 2004 May; 43(10):1880-5. PubMed ID: 15145115
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure.
Tang WH; Tong W; Troughton RW; Martin MG; Shrestha K; Borowski A; Jasper S; Hazen SL; Klein AL
J Am Coll Cardiol; 2007 Jun; 49(24):2364-70. PubMed ID: 17572253
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
12. Plasma urocortin in human systolic heart failure.
Ng LL; Loke IW; O'Brien RJ; Squire IB; Davies JE
Clin Sci (Lond); 2004 Apr; 106(4):383-8. PubMed ID: 14651473
[TBL] [Abstract][Full Text] [Related]
13. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
Song HM; Zhang J; Deng B; Luo M
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
[TBL] [Abstract][Full Text] [Related]
14. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
15. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
16. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
17. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
18. Relation of heart rate turbulence to severity of heart failure.
Cygankiewicz I; Zareba W; Vazquez R; Vallverdu M; Cino J; Cinca J; Almendral J; Gonzalez Juanatey JR; Macaya C; Valdes M; Caminal P; Bayes de Luna A
Am J Cardiol; 2006 Dec; 98(12):1635-40. PubMed ID: 17145225
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies.
Randa Abdel Kader M; Grace BD; Badawi NE
Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350
[TBL] [Abstract][Full Text] [Related]
20. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure.
Kotlyar E; Vita JA; Winter MR; Awtry EH; Siwik DA; Keaney JF; Sawyer DB; Cupples LA; Colucci WS; Sam F
J Card Fail; 2006 Mar; 12(2):122-7. PubMed ID: 16520260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
